Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Anochlesia

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Anochlesia in 3 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, WJ3
Mayerhofer, A2
Meyer, A1
Kovar, KA2
Banjaw, MY1
Lebsanft, HB1
Kohles, T1

Other Studies

3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Anochlesia

ArticleYear
Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
    Neuroscience letters, 2002, Sep-27, Volume: 330, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Animals; Catalepsy; Dopamine Antagonist

2002
Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat.
    Synapse (New York, N.Y.), 2003, Sep-15, Volume: 49, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Alkaloids; Animals; Catalepsy; Central Nervous System; Central Nervous

2003
3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
    Synapse (New York, N.Y.), 2005, Mar-01, Volume: 55, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Denervatio

2005